Anxiety Disorders Completed Phase 2 Trials for Ketamine (DB01221)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00749203Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)Treatment